STAT Partners With Slingshot Insights to Bring Expert Analysis in the Health Care Space to Investors
STAT, a national life sciences news organization, has partnered with Slingshot Insights to launch STAT Expert Advantage, a new service connecting health care investors with subject matter experts and top-tier industry reporters.
STAT, a national life sciences news organization, has partnered with
Slingshot Insights to launch STAT Expert Advantage, a new service
connecting health care investors with subject matter experts and
top-tier industry reporters.
Since its launch in 2015, STAT (www.statnews.com)
has emerged as the leading news organization covering health and
medicine. Slingshot Insights (www.slingshotinsights.com)
is the first crowdfunded expert network and due diligence community
focused on health care.
STAT Expert Advantage is a collaboration between STAT and Slingshot
Insights that brings together key opinion leaders and STAT beat
reporters to help investors make smarter investments. Members get access
to exclusive monthly interviews conducted by STAT staff. Calls cover
timely topics that are top of mind for investors — from impending
clinical trial results and FDA advisory committee meetings to
legislation expected to shape the industry.
Reporters, including STAT’s senior medicine writer, Matthew Herper, and
STAT senior biotech writer Adam Feuerstein, will rotate on calls,
interviewing experts about the most interesting and investable topics on
their beats. The series will also leverage the expertise of STAT staff
spread across the country, in Boston, Washington, San Francisco, and New
York.
Professional portfolio managers have used expert calls and management
meetings for decades to quickly get insights on market-moving news. In
spending over $600 million annually in 2015 on this type of research,
financial institutions are able to intelligently invest in a broad range
of companies using expert knowledge. Individual investors, however, have
traditionally had to make decisions without these tools. STAT Expert
Advantage helps bridge this gap.
Slingshot Insights CEO Joe McCann said: “We’re very excited about this
new joint venture with STAT, which has established itself as the go-to
destination for health care and biotech news. By communicating directly
with this tremendously engaged community, we will strengthen not only
the quality of our interviews, but the Slingshot community overall. Our
goal at Slingshot is to cut through the noise, verifying management
claims, evaluating clinical trials results, and making sure members have
the full story when making an investment decision.”
Members have access to 12 expert calls a year. Those calls are recorded
and transcribed, allowing members to access the information on their
time. The platform allows members to submit questions for experts before
each call. STAT Expert Advantage ensures compliance, while maintaining
the quality and user-directed nature of traditional expert calls.
STAT Chief Revenue Officer Angus Macaulay remarked: “We’re excited to
partner with Slingshot Insights to develop this innovative product. For
over three years our readers have come to rely on STAT for exclusive
insights and analysis of the life sciences. STAT Expert Advantage offers
us the opportunity to take our readers deeper by leveraging the
expertise of our reporters, key opinion leaders, and the Slingshot
Insights platform.”
To learn more about the exclusive benefits for STAT members, visit www.slingshotinsights.com/stat
today.
ABOUT STAT
STAT delivers fast, deep, and tough-minded
journalism about life sciences and the fast-moving business of making
medicines. We take you inside academic labs, biotech boardrooms, and
political backrooms.
www.statnews.com/
Twitter:
@statnews
ABOUT SLINGSHOT INSIGHTS
Slingshot Insights is an expert
network that utilizes technology to reduce the time, cost, and
compliance risks associated with expert research.
www.SlingshotInsights.com
Twitter:
@Slingshot_Invst
View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005758/en/